Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Cash & Equivalents (2010 - 2026)

Veru (VERU) posted quarterly Cash & Equivalents of $27.6 million for Q1 2026, up 37.86% year-over-year from $20.0 million in Q1 2025, and down 16.35% quarter-over-quarter from $33.0 million in Q4 2025.

Veru (VERU) Cash & Equivalents (2010 - 2026) Analysis & Trends

Veru (VERU) has reported Cash & Equivalents for 17 consecutive years, with $27.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 37.86% year-over-year to $27.6 million; the TTM figure through Mar 2026 stood at $27.6 million (up 37.86% YoY), while the FY2025 annual figure was $15.8 million, down 36.61% from the prior year.
  • Cash & Equivalents slipped to $27.6 million in Q1 2026 per VERU's latest filing, from $33.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $112.0 million in Q1 2022 and bottomed at $9.6 million in Q3 2023.
  • Historically, Cash & Equivalents has averaged $38.6 million across 5 years, with a median of $27.6 million in 2026.
  • Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 88.0% — and 2024, when it jumped 158.86%.
  • Veru's Cash & Equivalents stood at $46.9 million in 2022, then declined by 13.53% to $40.6 million in 2023, then slumped by 34.43% to $26.6 million in 2024, then rose by 24.0% to $33.0 million in 2025, then fell by 16.35% to $27.6 million in 2026.
  • Business Quant data shows VERU's Cash & Equivalents at $27.6 million in Q1 2026, $33.0 million in Q4 2025, and $15.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Veru 60.85 Mn 35.06 Mn - 23.88 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 23.88 Mn
Mar 31, 2026 27.60 Mn
Dec 31, 2025 32.99 Mn
Sep 30, 2025 15.79 Mn
Jun 30, 2025 15.01 Mn
Mar 31, 2025 20.02 Mn
Dec 31, 2024 26.61 Mn
Sep 30, 2024 24.92 Mn
Jun 30, 2024 29.15 Mn
Mar 31, 2024 34.74 Mn
Dec 31, 2023 40.58 Mn
Sep 30, 2023 9.63 Mn
Jun 30, 2023 16.21 Mn
Mar 31, 2023 23.50 Mn
Dec 31, 2022 46.93 Mn
Sep 30, 2022 80.19 Mn
Jun 30, 2022 100.55 Mn
Mar 31, 2022 112.02 Mn
Dec 31, 2021 116.10 Mn
Sep 30, 2021 122.36 Mn